Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Ecotoxicol Environ Saf ; 249: 114359, 2023 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-36508797

RESUMEN

Silicosis is a diffuse fibrotic lung disease in which excessive inflammatory responses are triggered by silica exposure. Pyroptosis, a pro-inflammatory mode of programmed cell death, is mediated by gasdermin and may play a pivotal role in the development of silicosis. The caspase-1 inhibitor, VX-765, was used in vivo and in vitro to investigate the effects of silica-induced early inflammatory injury and later lung fibrosis. Our findings show that VX-765 reduces inflammatory lung injury by inhibiting silica-induced pyroptosis of alveolar macrophages in a silicosis mouse model. VX-765 limits the infiltration of inflammatory M1 alveolar macrophages, decreasing expression of inflammatory cytokines, including IL-1ß, TNF-α, IL-6, CCL2, and CCL3, and down-regulating endogenous DAMPs and inflammatory immune-related cell pattern recognition receptors TLR4 and NLRP3. Furthermore, VX-765 alleviates fibrosis by down-regulating α-smooth muscle actin (α-SMA), collagen, and fibronectin. In this study, we illustrate that Alveolar macrophages pyroptosis occur in the early stages of silicosis, and VX-765 can alleviate the development of silicosis by inhibiting the pyroptosis signaling pathway. These results may provide new insight into the prevention and treatment of early-stage silicosis.


Asunto(s)
Inhibidores de Caspasas , Lesión Pulmonar , Fibrosis Pulmonar , Piroptosis , Silicosis , Animales , Ratones , Lesión Pulmonar/inducido químicamente , Lesión Pulmonar/tratamiento farmacológico , Lesión Pulmonar/patología , Macrófagos Alveolares/efectos de los fármacos , Piroptosis/efectos de los fármacos , Dióxido de Silicio/toxicidad , Silicosis/tratamiento farmacológico , Inhibidores de Caspasas/farmacología , Inhibidores de Caspasas/uso terapéutico , Fibrosis Pulmonar/inducido químicamente , Fibrosis Pulmonar/tratamiento farmacológico
2.
Toxicol Lett ; 355: 150-159, 2022 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-34843873

RESUMEN

Silicosis is a disease characterized by extensive lung nodules and fibrosis caused by the prolonged inhalation of silica in occupational settings. However, the molecular mechanism of silicosis development is complex and not fully understood. Furthermore, the role of necroptosis, a death receptor-mediated and caspase-independent mode of inflammatory cell death, is not well understood in silicosis. Here, we demonstrate that the necroptotic signaling pathway of macrophages is significantly activated in the lungs of silicosis mouse models. Meanwhile, increased M1 macrophage infiltration and up-regulation of pro-inflammatory cytokines (TNF-α, IL-6) were observed in our silicosis model. Notably, the expression of the pro-fibrotic factor, TGF-ß1, and fibrosis biomarkers α-SMA and collagen I were also unregulated; however, these phenomena were recovered by Nec-1, an inhibitor specific for RIP1 kinase-dependent necroptosis. We conclude that macrophage-mediated necroptosis promotes the progression of silicosis by enhancing lung inflammatory responses and fibrogenesis in a mouse model of silicosis. These findings provide new insights for drug discovery and clinical treatment of silicosis.


Asunto(s)
Inflamación/inducido químicamente , Macrófagos Alveolares/efectos de los fármacos , Necroptosis/efectos de los fármacos , Fibrosis Pulmonar/inducido químicamente , Dióxido de Silicio/toxicidad , Silicosis/patología , Animales , Relación Dosis-Respuesta a Droga , Imidazoles/farmacología , Indoles/farmacología , Masculino , Ratones , Ratones Endogámicos C57BL , Transducción de Señal , Dióxido de Silicio/administración & dosificación , Regulación hacia Arriba
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...